Literature DB >> 22051348

Genetic co-morbidity between neuroticism, anxiety/depression and somatic distress in a population sample of adolescent and young adult twins.

N K Hansell1, M J Wright, S E Medland, T A Davenport, N R Wray, N G Martin, I B Hickie.   

Abstract

BACKGROUND: Genetic studies in adults indicate that genes influencing the personality trait of neuroticism account for substantial genetic variance in anxiety and depression and in somatic health. Here, we examine for the first time the factors underlying the relationship between neuroticism and anxiety/depressive and somatic symptoms during adolescence.
METHOD: The Somatic and Psychological Health Report (SPHERE) assessed symptoms of anxiety/depression (PSYCH-14) and somatic distress (SOMA-10) in 2459 adolescent and young adult twins [1168 complete pairs (35.4% monozygotic, 53% female)] aged 12-25 years (mean=15.5 ± 2.9). Differences between boys and girls across adolescence were explored for neuroticism, SPHERE-34, and the subscales PSYCH-14 and SOMA-10. Trivariate analyses partitioned sources of covariance in neuroticism, PSYCH-14 and SOMA-10.
RESULTS: Girls scored higher than boys on both neuroticism and SPHERE, with SPHERE scores for girls increasing slightly over time, whereas scores for boys decreased or were unchanged. Neuroticism and SPHERE scores were strongly influenced by genetic factors [heritability (h(2)) = 40-52%]. A common genetic source influenced neuroticism, PSYCH-14 and SOMA-10 (impacting PSYCH-14 more than SOMA-10). A further genetic source, independent of neuroticism, accounted for covariation specific to PSYCH-14 and SOMA-10. Environmental influences were largely specific to each measure.
CONCLUSIONS: In adolescence, genetic risk factors indexed by neuroticism contribute substantially to anxiety/depression and, to a lesser extent, perceived somatic health. Additional genetic covariation between anxiety/depressive and somatic symptoms, independent of neuroticism, had greatest influence on somatic distress, where it was equal in influence to the factor shared with neuroticism.

Entities:  

Mesh:

Year:  2011        PMID: 22051348     DOI: 10.1017/S0033291711002431

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  28 in total

1.  Youth Early-intervention Study (YES) - group interventions targeting social participation and physical well-being as an adjunct to treatment as usual: study protocol for a randomized controlled trial.

Authors:  Lillian Jean Gehue; Elizabeth Scott; Daniel Francis Hermens; Jan Scott; Ian Hickie
Journal:  Trials       Date:  2015-08-05       Impact factor: 2.279

2.  Associations between depression and anxiety symptoms and retinal vessel caliber in adolescents and young adults.

Authors:  Madeline H Meier; Nathan A Gillespie; Narelle K Hansell; Alex W Hewitt; Ian B Hickie; Yi Lu; Stuart MacGregor; Sarah E Medland; Cong Sun; Tien Y Wong; Margaret J Wright; Gu Zhu; Nicholas G Martin; David A Mackey
Journal:  Psychosom Med       Date:  2014 Nov-Dec       Impact factor: 4.312

3.  Common Etiological Sources of Anxiety, Depression, and Somatic Complaints in Adolescents: A Multiple Rater twin Study.

Authors:  Helga Ask; Trine Waaktaar; Karoline Brobakke Seglem; Svenn Torgersen
Journal:  J Abnorm Child Psychol       Date:  2016-01

4.  Dynamic networks of psychological symptoms, impairment, substance use, and social support: The evolution of psychopathology among emerging adults.

Authors:  Jacob J Crouse; Nicholas Ho; Jan Scott; Richard Parker; Shin Ho Park; Baptiste Couvy-Duchesne; Brittany L Mitchell; Enda M Byrne; Daniel F Hermens; Sarah E Medland; Nicholas G Martin; Nathan A Gillespie; Ian B Hickie
Journal:  Eur Psychiatry       Date:  2022-06-13       Impact factor: 7.156

5.  Does caregiving cause psychological distress? The case for familial and genetic vulnerabilities in female twins.

Authors:  Peter P Vitaliano; Eric Strachan; Elizabeth Dansie; Jack Goldberg; Dedra Buchwald
Journal:  Ann Behav Med       Date:  2014-04

6.  The Brisbane Longitudinal Twin Study: Pathways to Cannabis Use, Abuse, and Dependence project-current status, preliminary results, and future directions.

Authors:  Nathan A Gillespie; Anjali K Henders; Tracy A Davenport; Daniel F Hermens; Margie J Wright; Nicholas G Martin; Ian B Hickie
Journal:  Twin Res Hum Genet       Date:  2012-11-28       Impact factor: 1.587

7.  Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample.

Authors:  Tomislav D Zbozinek; Raphael D Rose; Kate B Wolitzky-Taylor; Cathy Sherbourne; Greer Sullivan; Murray B Stein; Peter P Roy-Byrne; Michelle G Craske
Journal:  Depress Anxiety       Date:  2012-11-26       Impact factor: 6.505

Review 8.  Redefining phenotypes to advance psychiatric genetics: Implications from hierarchical taxonomy of psychopathology.

Authors:  Monika A Waszczuk; Nicholas R Eaton; Robert F Krueger; Alexander J Shackman; Irwin D Waldman; David H Zald; Benjamin B Lahey; Christopher J Patrick; Christopher C Conway; Johan Ormel; Steven E Hyman; Eiko I Fried; Miriam K Forbes; Anna R Docherty; Robert R Althoff; Bo Bach; Michael Chmielewski; Colin G DeYoung; Kelsie T Forbush; Michael Hallquist; Christopher J Hopwood; Masha Y Ivanova; Katherine G Jonas; Robert D Latzman; Kristian E Markon; Stephanie N Mullins-Sweatt; Aaron L Pincus; Ulrich Reininghaus; Susan C South; Jennifer L Tackett; David Watson; Aidan G C Wright; Roman Kotov
Journal:  J Abnorm Psychol       Date:  2019-12-05

9.  Clinical classification in mental health at the cross-roads: which direction next?

Authors:  Ian B Hickie; Jan Scott; Daniel F Hermens; Elizabeth M Scott; Sharon L Naismith; Adam J Guastella; Nick Glozier; Patrick D McGorry
Journal:  BMC Med       Date:  2013-05-14       Impact factor: 8.775

10.  Circadian profiles in young people during the early stages of affective disorder.

Authors:  S L Naismith; D F Hermens; T K C Ip; S Bolitho; E Scott; N L Rogers; I B Hickie
Journal:  Transl Psychiatry       Date:  2012-05-29       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.